Skip to main content

Brant Allen Inman, MD, MS

Cary N. Robertson, MD, Associate Professor
Associate Professor of Surgery
Office: 3007 Snyderman Bldg, 905 La Salle Street, Durham, NC 27710
Campus Mail: DUMC DUMC Box 103868, Durham, NC 27710

Clinical research interests:
Clinical trials of novel diagnostic tests and therapies for genitourinary malignancies, with a strong focus on bladder cancer.

Basic science research interests:
Immune therapies for cancer, hyperthermia and heat-based treatment of cancer, molecular biology of genitourinary cancers, novel diagnostics and therapies for genitourinary cancers

Education and Training

  • Fellowship, Urologic Oncology, Mayo Clinic, 2005 - 2008
  • Residency, Urology, Universite Laval (Canada), 2001 - 2005
  • M.S., Mayo Medical School, 2011
  • M.D., University of Alberta (Canada), 2000
  • B.S., University of Alberta (Canada), 1999

Publications

Vo-Dinh, T., B. Inman, P. Maccarini, G. Palmer, and Y. Liu. “Synergistic immuno photothermal nanotherapy (SYMPHONY) to treat metastatic cancers and induce anti-cancer vaccine effect.” In Progress in Biomedical Optics and Imaging  Proceedings of Spie, Vol. 10484, 2018. https://doi.org/10.1117/12.2300089.

Full Text

Brousell, Steven C., Joseph J. Fantony, Megan G. Van Noord, Michael R. Harrison, and Brant A. Inman. “Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy..” Core Evid 13 (2018): 1–12. https://doi.org/10.2147/CE.S118670.

Full Text

Vo-Dinh, Tuan, and Brant A. Inman. “What potential does plasmonics-amplified synergistic immuno photothermal nanotherapy have for treatment of cancer?.” Nanomedicine (Lond) 13, no. 2 (January 2018): 139–44. https://doi.org/10.2217/nnm-2017-0356.

Full Text

Shore, Neal D., Stephen A. Boorjian, Daniel J. Canter, Kenneth Ogan, Lawrence I. Karsh, Tracy M. Downs, Leonard G. Gomella, et al. “Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study..” J Clin Oncol 35, no. 30 (October 20, 2017): 3410–16. https://doi.org/10.1200/JCO.2017.72.3064.

Full Text

Spiess, Philippe E., Neeraj Agarwal, Rick Bangs, Stephen A. Boorjian, Mark K. Buyyounouski, Peter E. Clark, Tracy M. Downs, et al. “Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology..” J Natl Compr Canc Netw 15, no. 10 (October 2017): 1240–67. https://doi.org/10.6004/jnccn.2017.0156.

Full Text

Gopalakrishna, Ajay, Thomas A. Longo, Joseph J. Fantony, Michael R. Harrison, and Brant A. Inman. “Physical activity patterns and associations with health-related quality of life in bladder cancer survivors..” Urol Oncol 35, no. 9 (September 2017): 540.e1-540.e6. https://doi.org/10.1016/j.urolonc.2017.04.016.

Full Text

Liu, Yang, Paolo Maccarini, Gregory M. Palmer, Wiguins Etienne, Yulin Zhao, Chen-Ting Lee, Xiumei Ma, Brant A. Inman, and Tuan Vo-Dinh. “Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers..” Sci Rep 7, no. 1 (August 17, 2017). https://doi.org/10.1038/s41598-017-09116-1.

Full Text

Gopalakrishna, Ajay, Joseph J. Fantony, Thomas A. Longo, Richmond Owusu, Wen-Chi Foo, Rajesh Dash, Brian T. Denton, and Brant A. Inman. “Anticipatory Positive Urine Tests for Bladder Cancer..” Ann Surg Oncol 24, no. 6 (June 2017): 1747–53. https://doi.org/10.1245/s10434-016-5763-5.

Full Text

Inman, B. A., and J. J. Fantony. “Authors' reply to letter to editor: "reply to 'it may be time to abandon urine tests for bladder cancer'".” Jnccn Journal of the National Comprehensive Cancer Network 15, no. 5 (May 1, 2017): lxxi–lxxii.

Scholars@Duke

Pages